Obexelimab met the primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo over weeks ...
InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for Drug Evaluation (CDE) of ...
The actress, whose new memoir is out next month, jokes that she rates the disease "zero stars," adding, "Would not recommend" ...
Also, don’t miss A Special Kind of Existence Art by Jeff Musser on the Pacifica Patch calendar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results